{"filing":{"accession_number":"0001493152-26-040845","cik":"0001178697","ticker":"SONM","company_name":"DNA X, Inc.","form":"8-K","filing_date":"2026-08-31","report_date":"2026-08-28","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1178697/000149315226040845/form8-k.htm"},"events":[{"id":30672,"run_id":28119,"accession_number":"0001493152-26-040845","anchor_item_number":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"DNA X received notice from Nasdaq's Hearings Panel on August 28, 2026 that while the Company has regained compliance with the stockholders' equity requirement (Nasdaq Listing Rule 5550(b)(1)), its securities remain subject to delisting if compliance is not maintained until November 18, 2026. Additionally, the Company is subject to a mandatory panel monitor through August 28, 2027, with the explicit warning that any future non-compliance will result in immediate delisting determination without opportunity for a compliance plan or cure period. This is a material delisting risk disclosure under Item 8.01.","company_name":"DNA X, Inc.","ticker":"SONM","filing_date":"2026-08-31","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":33340,"accession_number":"0001493152-26-040845","item_number":null,"item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"DNA X received notice from Nasdaq's Hearings Panel on August 28, 2026 that while the Company has regained compliance with the stockholders' equity requirement (Nasdaq Listing Rule 5550(b)(1)), its securities remain subject to delisting if compliance is not maintained until November 18, 2026. Additionally, the Company is subject to a mandatory panel monitor through August 28, 2027, with the explicit warning that any future non-compliance will result in immediate delisting determination without opportunity for a compliance plan or cure period. This is a material delisting risk disclosure under Item 8.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T21:00:48.623461+00:00","company_name":"DNA X, Inc.","ticker":"SONM","filing_date":"2026-08-31"}]}